BeiGene, Ltd. (BGNE)
Last Price$226.70.0%
Market Cap$1,846.9M
50.5%
Industry median - 12.9%
5Y Historical average - 81.6%
(32.5%)
Industry median - 1.0%
5Y Historical average - 14.3%
(16.6%)
Industry median - (20.7%)
5Y Historical average - (0.4%)
(45.5%)
Industry median - (1.6%)
5Y Historical average - 19.5%
BGNE Growth Rating
Crunching data... Almost there!
BGNE Growth Metrics
Crunching data... Almost there!
Competing with BGNE Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the BeiGene, Ltd. (BGNE) revenue growth?
The BeiGene, Ltd. (BGNE) revenue growth is 50.5%, which is lower than the industry median of 12.9% and the 5-year historical average of 81.6%.
What is the BeiGene, Ltd. (BGNE) operating income growth?
The BeiGene, Ltd. (BGNE) operating income growth is (32.5%), compared to the industry median of 1.0% and the 5-year historical average of 14.3%.
What is the BeiGene, Ltd. (BGNE) EPS (Earnings Per Share) growth?
The BeiGene, Ltd. (BGNE) EPS growth is (16.6%), compared to the industry median of (20.7%) and the 5-year historical average of (0.4%).
What is the BeiGene, Ltd. (BGNE) Free Cash Flow (FCF) growth?
The BeiGene, Ltd. (BGNE) Free Cash Flow growth is (45.5%), compared to the industry median of (1.6%) and the 5-year historical average of 19.5%.